Propred

Propred predicts Major Histocompatibility Complex (MHC) class II binding regions in antigenic protein sequences to identify promiscuous HLA-DR–binding epitopes for immunological research and vaccine design.

Key Features:

• Sequence input processing: Processes antigenic protein sequences as inputs for MHC class II binding prediction.
• Matrix-based prediction algorithm: Implements a matrix-based algorithm to predict MHC class II binding using position-specific coefficients.
• Amino-acid/position coefficient table: Utilizes an amino-acid/position coefficient table derived from existing literature to inform predictions.
• Promiscuous binding region identification: Identifies regions capable of binding multiple HLA-DR alleles (promiscuous binders).

Scientific Applications:

• Epitope identification for vaccine design: Predicts MHC class II (HLA-DR) binding regions to support selection of promiscuous epitopes for broad-population vaccine targets.
• Antigen presentation studies: Supports studies of antigen presentation and MHC class II interactions in immunology research.
• Autoimmune disease research: Aids investigation of peptide–MHC class II interactions relevant to autoimmune disease mechanisms.
• Therapeutic and personalized medicine development: Informs design of peptide-based therapeutics and personalized immunotherapy approaches.

Methodology:

Input antigenic protein sequences are analyzed by a matrix-based prediction algorithm that applies an amino-acid/position coefficient table derived from literature to predict MHC class II binding regions.